Symptom-centric view
Wrong technique in product usage process
Substances reporting Wrong technique in product usage process disproportionately — ranked by ROR.
showing 5 of 5
| Substance ↓ | ROR [95% CI] | Reports | Category | Label |
|---|---|---|---|---|
semaglutide Ozempic · Wegovy | 3.8 [3.6–3.9] | 2,899 | glp-1 | new |
minoxidil Rogaine · Loniten | 2.8 [2.6–2.9] | 1,150 | glp-1 | new |
| 3.8 [3.1–4.8] | 76 | longevity | new | |
bimatoprost Latisse · Lumigan | 2.2 [2.0–2.3] | 584 | injectables | new |
| 3.0 [2.8–3.2] | 703 | algemeen | new |
ROR = reporting odds ratio vs. the full FAERS corpus. A signal is not a cause. Source: openFDA (FAERS).